Analyst Ratings for Constellation Pharmaceuticals (CNST)

CNST Rating Summary

CNST Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CNST
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $35.25 (+3.7%) * Over Last 12-Mos
Rating Score: 3.3 / 10   Percentile Rank: 28%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/17/2021 RBC Capital Brian Abrahams Downgrade Sector Perform
(Outperform)
34.00
(50.00)
33.69
(33.99)
0.89% Details
6/4/2021 Jefferies Biren Amin Downgrade Hold
(Buy)
34.00
(53.00)
33.57
(33.99)
1.25% Details
Like CNST Ratings? Also take a look at MOR, RPRX, FMBI, SLCT

CNST Ratings News